Stock Comparison
ABBV vs PFE
AbbVie Inc and Pfizer Inc side by side — valuation, profitability, growth and risk.
Valuation
Market Cap
$447.62B
$138.44B
P/E (TTM)
123.6
18.5
Forward P/E
17.8
8.2
Price/Sales
7.1
2.2
Price/Book
50.5
1.5
EV/EBITDA
30.2
11.0
Dividend Yield
2.77%
7.27%
Profitability
Net Margin
5.79%
11.80%
Operating Margin
32.20%
31.60%
Return on Equity
62.30%
8.31%
Return on Assets
10.00%
5.69%
Growth (YoY)
Revenue Growth
12.40%
5.40%
Earnings Growth
-46.20%
-10.10%
Price & Risk
Beta
0.3
0.3
52-Week High
$253.35
$28.28
52-Week Low
$176.02
$21.97
Analyst Target
$254.38
$29.15
Compare ABBV and PFE your own way
Try mrmarket.ai freeFigures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.